Drug Trial Radar · NCT04355689
Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
Last checked: Nov 19, 2026Latest source record: Jul 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
49
Actual
Start
Sep 3, 2020
Primary completion
Jun 20, 2025
Study completion Apr 22, 2026
Sponsor
- Lead sponsor
- Nacuity Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Foundation Fighting Blindness; Nacuity Pharmaceuticals, PTY LTD
- First posted
- Apr 21, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will examine the safety and efficacy of NPI-001 Tablets as compared to placebo for 24 months in subjects with vision loss due to RP associated with Usher syndrome.
Conditions
- Usher Syndromes
Interventions
NPI-001Drug
oral tablet
PlaceboOther
Placebo tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate change from baseline for retinal sensitivity assessed by microperimetry of active versus placeboTime frame: 24 months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Queensland Eye Institute
Brisbane, Australia
CERA
Melbourne, Australia
Lions Eye Institute
Perth, Australia
Sydney Eye Hospital / Save Sight Institute
Sydney, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.